Hyderabad (Telangana) [India], September 6 (ANI): Hetero announced on Monday that the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab in India for the treatment of COVID-19 in hospitalised adults.
Beijing [China], April 30 (ANI): An antibody treatment, using the drug tocilizumab, may be represented as an effective option in severe coronavirus cases, according to a preliminary report by Xiaoling Xu et al, published in PNAS.